White Paper

Alternatives to the High Cost of Topicals for Pain Management

CorVel has witnessed topical costs rise following the recent drop in opioid prescriptions, and now offers alternatives to manage their expense without impacting care.

White Paper Summary

As health care providers across the nation divert patients away from opioids — now deemed a dangerous class of medications for pain management — the use of some high-cost topicals has soared.

CorVel, a national leader in risk management with over 20 years of experience providing pharmacy benefit management services, estimates a 56% increase in topical medication dispensing over the past five years based on pharmacy data across its book of business.

“It’s been a dramatic and costly increase for employers,” said Ryan Hamm, Pharm. D., clinical pharmacist at CorVel. “We are paying close attention to the dispensing of some high-cost topical analgesics and actively working to rein in costs.”

One of CorVel’s approaches is to evaluate the prescription of high-cost topicals and, when needed, convert them to alternative medications that are less costly but just as effective for injured workers.

To learn more about CorVel, please visit their website.

CorVel is a national provider of risk management solutions for employers, third party administrators, insurance companies and government agencies seeking to control costs and promote positive outcomes.

More from Risk & Insurance